Mercer Global Advisors
FMED icon

Mercer Global Advisors’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Mercer Global Advisors’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.43K Buy
+50
New +$1.27K ﹤0.01% 5670

Other funds holding FMED

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

Mercer Global Advisors's FMED Position: Q2 2026 in Review

Mercer Global Advisors opened a new position in Fidelity Disruptive Medicine ETF (FMED) in Q2 2026: 50 shares worth $1.43K. The stake represents ﹤0.01% of the portfolio and ranks #5670 among its holdings.

6 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

  • Mercer Global Advisors held 50 shares of Fidelity Disruptive Medicine ETF worth $1.43K as of Q2 2026.
  • Fidelity Disruptive Medicine ETF was a new Mercer Global Advisors position in Q2 2026.
  • Fidelity Disruptive Medicine ETF made up ﹤0.01% of Mercer Global Advisors's portfolio in Q2 2026, its #5670 holding.
  • 6 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Mercer Global Advisors's 13F filing for Q2 2026, filed 11 Aug 2026.